Metformin-Therapie bei PCO-Syndrom - Positive Vierjahresbilanz des oralen Antidiabetikums

The Polycystic ovary syndrome (PCOS) is the most frequent endocrinal disease of women in child-bearing age. PCOS represents a high risk for infertility, metabolic and cardiovascular diseases. This article analyses the outcomes after four years of PCOS-treatment with Metformin, an orally administered medication. We describe under which circumstances Metformin treatment is useful.

26. September 2008

Authors D. Albrecht P. Kaltwasser E. Rosenkranz Dirk Trocka

Whom to contact

For Researchers

For Journalists

Mitglied der Leibniz-Gemeinschaft LogoTotal-Equality-LogoSupported by the BMWK